EUVIMEDEUVIMED entdecken
Vergleichsstudie

Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration

Jurij Hanzel iD, Christopher Ma iD, Theshani Amalka De Silva, Lotus Alphonsus, Leonardo Guizzetti, Eileen Crowley iD, Siddharth Singh iD, Vipul Jairath iD

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izad168 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Jurij Hanzel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, United States Food and Drug Administration, Drug Approval. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesUnited States Food and Drug AdministrationDrug ApprovalHumansUnited StatesEuropeTime FactorsGastrointestinal Agents

Stichwörter der Autor:innen

clinical trialsdrug approvalregulatory agency

Substanzen

Gastrointestinal Agents

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia.
  • Alimentiv Inc, London, ON, Canada.
  • Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
  • Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
  • Independent statistical consultant, London, ON, Canada.

ORCID-Profile: Jurij Hanzel, Christopher Ma, Eileen Crowley, Siddharth Singh, Vipul Jairath

Zitieren

APA

Hanzel, J., Ma, C., De Silva, T. A., Alphonsus, L., Guizzetti, L., Crowley, E., Singh, S., & Jairath, V. (2024). Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad168

Vancouver

Hanzel J, Ma C, De Silva TA, Alphonsus L, Guizzetti L, Crowley E, et al. Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad168

BibTeX
@article{Hanzel2024,
  author = {Hanzel, Jurij and Ma, Christopher and De Silva, Theshani Amalka and Alphonsus, Lotus and Guizzetti, Leonardo and Crowley, Eileen and Singh, Siddharth and Jairath, Vipul},
  title = {Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izad168}
}
Kostenlos starten →